Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 591

1.

The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity.

Frigolet ME, Torres N, Tovar AR.

J Nutr Biochem. 2013 Dec;24(12):2003-15. doi: 10.1016/j.jnutbio.2013.07.002. Epub 2013 Oct 9. Review.

PMID:
24120291
2.

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiéra F, Sharma AM.

Int J Biochem Cell Biol. 2003 Jun;35(6):807-25. Review.

PMID:
12676168
3.

Local adipose tissue renin-angiotensin system.

Cassis LA, Police SB, Yiannikouris F, Thatcher SE.

Curr Hypertens Rep. 2008 Apr;10(2):93-8. Review.

4.

Angiotensin receptor-binding protein ATRAP/Agtrap inhibits metabolic dysfunction with visceral obesity.

Maeda A, Tamura K, Wakui H, Dejima T, Ohsawa M, Azushima K, Kanaoka T, Uneda K, Matsuda M, Yamashita A, Miyazaki N, Yatsu K, Hirawa N, Toya Y, Umemura S.

J Am Heart Assoc. 2013 Jul 31;2(4):e000312. doi: 10.1161/JAHA.113.000312.

5.

The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms.

Kalupahana NS, Moustaid-Moussa N.

Crit Rev Biochem Mol Biol. 2012 Jul-Aug;47(4):379-90. doi: 10.3109/10409238.2012.694843. Review.

PMID:
22720713
6.

The renin-angiotensin system: a link between obesity, inflammation and insulin resistance.

Kalupahana NS, Moustaid-Moussa N.

Obes Rev. 2012 Feb;13(2):136-49. doi: 10.1111/j.1467-789X.2011.00942.x. Epub 2011 Oct 31. Review.

PMID:
22034852
7.

Soya protein attenuates abnormalities of the renin-angiotensin system in adipose tissue from obese rats.

Frigolet ME, Torres N, Tovar AR.

Br J Nutr. 2012 Jan;107(1):36-44. doi: 10.1017/S0007114511002595. Epub 2011 Jun 22.

PMID:
21736766
8.

Adipose tissue dysfunction in obesity.

Blüher M.

Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8. Review.

PMID:
19358089
9.

Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension.

Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA.

Am J Physiol Regul Integr Comp Physiol. 2004 Oct;287(4):R943-9. Epub 2004 Jun 10.

10.

[Renin-angiotensin system in mesenteric adipose tissues in rats with metabolic syndrome].

Ma LQ, Zhang LL, Zhang YP, Wang LJ, Li ZB, Cao TB, Liu DY, Zhu ZM.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Dec;28(6):770-5. Chinese.

11.

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

Bays HE, González-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR.

Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68. doi: 10.1586/14779072.6.3.343. Review.

PMID:
18327995
12.

Oxidative stress and lipid peroxidation by-products at the crossroad between adipose organ dysregulation and obesity-linked insulin resistance.

Murdolo G, Piroddi M, Luchetti F, Tortoioli C, Canonico B, Zerbinati C, Galli F, Iuliano L.

Biochimie. 2013 Mar;95(3):585-94. doi: 10.1016/j.biochi.2012.12.014. Epub 2012 Dec 26. Review.

PMID:
23274128
13.

Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity.

Yvan-Charvet L, Quignard-Boulangé A.

Kidney Int. 2011 Jan;79(2):162-8. doi: 10.1038/ki.2010.391. Epub 2010 Oct 13. Review.

14.

Dietary t10,c12-CLA but not c9,t11 CLA reduces adipocyte size in the absence of changes in the adipose renin-angiotensin system in fa/fa Zucker rats.

DeClercq V, Zahradka P, Taylor CG.

Lipids. 2010 Nov;45(11):1025-33. doi: 10.1007/s11745-010-3469-1. Epub 2010 Sep 16.

15.

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome.

Maury E, Brichard SM.

Mol Cell Endocrinol. 2010 Jan 15;314(1):1-16. doi: 10.1016/j.mce.2009.07.031. Epub 2009 Aug 12. Review.

PMID:
19682539
16.

Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.

Leiter LA, Lewanczuk RZ.

Am J Hypertens. 2005 Jan;18(1):121-8. Review.

PMID:
15691626
17.

Adipose tissue and adipocyte dysregulation.

Lafontan M.

Diabetes Metab. 2014 Feb;40(1):16-28. doi: 10.1016/j.diabet.2013.08.002. Epub 2013 Oct 16. Review.

PMID:
24139247
18.
19.

Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism.

Blaj S, Stanciu S, Jurcut C, Ciobîcă L.

Rom J Intern Med. 2003;41(2):103-11. Review.

PMID:
15526495
20.

Obesity, essential hypertension and renin-angiotensin system.

Segura J, Ruilope LM.

Public Health Nutr. 2007 Oct;10(10A):1151-5. Review.

PMID:
17903324

Supplemental Content

Support Center